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Complementary studies showed abundant gene expression ofPutative subunits of the rat mesangial KATP: A type 2B sulfonyl-
Kir6.1, thereby establishing gene expression of both compo-urea receptor and an inwardly rectifying K channel.
nents of KATP.Background. Sulfonylurea agents exert their physiological
Conclusions. Based upon analogy to vascular smooth muscleeffects in many cell types via binding to specific sulfonylurea
cells (VSMC), there are at least two putative mesangial KATPreceptors (SUR). SUR couple to inwardly-rectifying K chan-
that most likely represent hetero-octamers, comprised of eithernel (Kir6.x) to form tetradimeric ATP-sensitive K channels
rSUR2B or mcSUR2 in complex with Kir6.1. Our results define(KATP). The SUR subunits confer ATP-sensitivity on KATP and
the mesangial SUR2B as the possible first link in a chain ofalso provide the binding sites for sulfonylureas and other phar-
cellular events that culminates in MC contraction and alteredmacological agents. Our previous work demonstrated that the
extracellular matrix metabolism following exposure to sulfo-exposure of mesangial cells (MC) to sulfonylureas generated
profound effects on MC glucose uptake and matrix metabolism nylureas. In addition, our results serve as the basis for the
and induced heightened cell contractility in association with future elucidation of the electrophysiologic characteristics of
Ca2 transients. Because these responses likely resulted from the mesangial KATP and the study of endogenous regulators of
the binding of sulfonylurea to a mesangial SUR2, we subse- mesangial cell contractility.
quently documented [3H]-glibenclamide binding to MC and
the gene expression of several mesangial SUR2 transcripts.
From these data, we inferred that MC expressed the compo-
Sulfonylureas such as tolazamide and glibenclamidenents of a mesangial KATP and sought to establish their presence
are oral hypoglycemic agents that are frequently utilizedin primary MC.
Methods. To obtain mesangial SUR2 cDNA sequences, during the treatment of type 2 diabetes mellitus [1]. The
rapid amplification of cDNA ends (RACE) was utilized. DNA elucidation of the mechanism by which these agents aug-
sequences were established by the fluorescent dye termination ment pancreatic  cell insulin secretion via their highmethod. Gene expression of mesangial SUR2 and Kir6.1/2 was
affinity type-1 sulfonylurea receptors (SUR1) has impelledexamined by reverse transcription polymerase chain reaction
a burgeoning field of investigation into pancreatic and(RT-PCR) and Northern analysis. SUR2 proteins were identi-
fied by immunoblotting of mesangial proteins from membrane- non-pancreatic SUR [2]. These receptors are members
enriched fractions with polyclonal antiserum directed against of the cystic fibrosis transmembrane regulator (CFTR)/
SUR2.
multidrug resistance protein (MRP) subfamily that isResults. RACE cloning yielded two mesangial SUR2 cDNAs
subsumed within the adenosine 5-triphosphate (ATP)-of 4.8 and 6.7 kbp whose open reading frames translated pro-
teins of 964 and 1535 aa, respectively. Using probes specific to binding cassette (ABC) superfamily [3, 4]. The two SUR
each cDNA, the presence of a unique, 5.5 kbp serum-regulated genes, SUR1 and SUR2, are encoded on separate chro-
mesangial SUR2 splice variant was established. The sequence mosomes and have been respectively designated, ABCC8
of this mesangial SUR2 (mcSUR2B) shares identity with the
and ABCC9 [5]. The SUR are predicted to have 17 trans-recently cloned rat SUR2B (rSUR2B), but, in comparison to
membrane-spanning helices organized into three do-rSUR2B, is truncated by 12 exons at the N-terminus where it
contains a unique insert of 16 aa. Immunoblotting studies with mains designated TM0, TM1, and TM2, separated by
anti-SUR2 antiserum demonstrated SUR2 proteins of 108 and two intracytoplasmic loops labeled NBF1 and NBF2,
170 kD in membrane-enriched fractions of MC protein extracts. each containing nucleotide-binding motifs. The SUR dif-
fer in their affinity for sulfonylureas and in their tissue
distribution. SUR1 is a high-affinity receptor expressedKey words: mesangial cell contraction, hypoglycemia, cell contraction,
potassium channels, glucose uptake, SUR2B, Kir6.1. by pancreatic  cells and brain, while the low-affinity
SUR2 is more ubiquitously expressed [2]. There are twoReceived for publication December 12, 2000
major alternatively spliced SUR2 variants, SUR2A andand in revised form December 4, 2001
Accepted for publication December 6, 2001 SUR2B, and the former is chiefly found in heart and
skeletal muscle, while the latter is localized to brain, 2002 by the International Society of Nephrology
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heart, liver, kidney, intestine, and vascular smooth mus- Dimethyl sulfoxide (DMSO), glibenclamide, antibio-
tics, Tween-20, and morpholinopropane sulfonic acid-cle [6, 7].
The ATP-sensitive K channels (KATP) are hetero- EDTA-sodium acetate (MESA) buffer were purchased
from Sigma-Aldrich Co. (St. Louis, MO, USA). RPMIoctamers of two subunits, a SUR and a weak inwardly-
rectifying K channel (Kir6.x) that associate with each 1640 culture medium, fetal calf serum (FCS) and RNA
sizing ladders were obtained from Life Technologiesother in a stoichiometry of 4:4. Ion-channel closure is
mediated by sulfonylurea binding or by increases of the (Gaithersburg, MD, USA). QuikHyb solution was pur-
chased from Stratagene (La Jolla, CA, USA). SMART-cytoplasmic ATP:ADP ratio. In KATP, SUR1 or SUR2
regulates the Kir6.x ion pore to which it is coupled [8–16]. RACE cloning kits and Advantage cDNA PCR en-
zyme mixes were obtained from Clontech (Palo Alto,The prototypical  cell KATP is a tetradimer of SUR1
and Kir6.2, whereas the cardiac and vascular smooth CA, USA). TOPO TA cloning kits and pCR2.1/TOPO
vectors were purchased from Invitrogen (Carlsbad, CA,muscle KATP are represented by (SUR2A:Kir6.2)4 and
(SUR2B:Kir6.1/2)4, respectively [17–24]. In previous stud- USA). RNA STAT-60 reagent was obtained from Tel-
Test, Inc. (Friendswood, TX, USA). Poly(A) RNA wasies, we established that the sulfonylurea tolazamide stim-
ulated rat mesangial cells (MC) to secrete increased isolated by magnetic bead separation (Roche Molecu-
lar Biochemicals, Indianapolis, IN, USA). [-32P]dCTPamounts of collagen [25, 26]. As in other extrapancreatic
tissues in which sulfonylureas amplify glucose uptake, we (3000 Ci/mmol) was purchased from New England Nu-
clear (Boston, MA, USA). Bicinchoninic acid proteinestablished that the enhancement of MC glucose uptake
occurred coincident with increased cytosol-to-membrane assay kits were purchased from Pierce Labs (Rockford,
IL, USA). Sodium dodecyl sulfate-polyacrylamide gelstranslocation of the glucose transporter, GLUT1 [26, 27].
The augmentation of hexose uptake was associated with (10%) were obtained from Bio-Rad (Hercules, CA,
USA). Chemiluminescent detection system kits (ECL)an increased secretion of autocrine transforming growth
factor beta-1 (TGF-1) and collagen accumulation. In were purchased from Amersham Pharmacia Biotech
(Piscataway, NJ, USA). The 4.3 kbp Eco RI restrictionaddition, glibenclamide induced sustained oscillatory
Ca2 transients in MC that coincided with heightened of rat SUR2 cDNA (pJGAR7) was generously provided
by Dr. Charles Burant (University of Michigan, Anncell contractility [28–33]. Further postulation that these
biological effects resulted from binding of sulfonylureas Arbor, MI, USA). Kir6.1/2 primer sets were gifts of Dr.
Stephen C. Hebert (Yale Univ., New Haven, CT, USA).to membranous receptors resulted in the initial charac-
terization of several low-affinity MC SUR2. One of these Rabbit anti-SUR2 immune serum was kindly donated to
our laboratory by Dr. Susumu Seino (Chiba University,was represented by a unique and dominant 5.5 kb SUR2
transcript, which we identified as mesangial SUR2B Tokyo, Japan).
(mcSUR2B) [28]. With the prospect that this transcript
Tissue cultureand possibly others encoded the SUR2 subunit of a mes-
angial KATP, we initiated a series of investigations to The cells used in all studies were primary MC out-
growths of glomerular explants of Munich-Wistar ratscharacterize the components that would comprise this
channel. The initial molecular characterization of the or our well characterized cloned rat mesangial cell line
16KC2 [26–28]. The latter are spindle-shaped cells thatmesangial KATP would thus render greater insight toward
our understanding of the cell-signaling events underlying form characteristic hillocks in confluent tissue cultures
and stain positively for vimentin, desmin and -smoothour previously observed functional data regarding sulfo-
nylureas and MC. muscle actin, but not for cytokeratin or factor VIII. Cel-
lular contraction occurs following exposure to either an-
giotensin II or arginine vasopressin. These cells also bear
METHODS
atrial natriuretic peptide (ANP) receptors and the Thy-1
Animals antigen on their surfaces. Except where noted, primary
MC or 16KC2 were seeded at a density of 5,000 cellsMale Munich-Wistar rats, weighing 150 to 200 g, were
obtained from Charles River Laboratories (Wilmington, per cm2 and cultured to near-confluence in RPMI 1640
medium, containing 8 mmol/L glucose, antibiotics (peni-MA, USA). Animals were housed in accordance with good
practice guidelines established by AALAC-approved cillin 100 U/mL; streptomycin 100 g/mL) and 20%
serum.animal care facilities of Henry Ford Hospital. Animals
were fed standard Purina rat chow (Ralston Purina Co.,
Cloning by rapid amplification of cDNASt. Louis, MO, USA) and permitted free access to water.
ends (RACE)
Reagents Poly(A) RNA was isolated on magnetic beads from
primary cell cultures at passage 8. RACE cloning wasInsulin-transferrin-selenium pre-mix was obtained from
Becton Dickinson Biosciences (Franklin Lakes, NJ, USA). carried out with the SMART-RACE system [7]. Briefly,
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Table 1. Gene-specific polymerase chain reaction (PCR) primers aldehyde gels at 100V. RNA was transferred to charged
nylon membranes by capillary action, UV light-cross-Primer Sequence
linked and hybridized at 68C in QuikHyb to cDNAGSP1B 5-tccttccagggtctgcatctcaccaa-3
GSP2B 5-AGGTGACGAACGGATACTTCTCATGG-3 probes, generated by random-priming in the presence of
GSP3B 5-aggaggagagacgatttgccacaacc-3 [-32P]dCTP. To evaluate SUR2 gene expression, three
GSP4B 5-TGACATTCGAATTCCAACAGGTCAGC-3
cDNA fragments were designed as templates for probeSUR013F 5-CCTGGAGGTTCAGACTCTTGG-3
SURORF5 5-GTCGACGTCCTTCAAGATGGACAGAAC synthesis. The first probe was unique to the full rSUR2B
ACTGC-3 sequence and synthesized from a 1.9 kbp Sac I fragment
SUR227R 5-gccttaggaagcagtgttctgtccat-3
of the 2.5 kbp 5-RACE product. A second 215 bp probeKIR61–2F 5-AGCCACTGACCTTGTCAACC-3
KIR61–2R 5-ggagtcatgaattgcacctt-3 was generated by polymerase chain reaction (PCR) with
KIR62–5F 5-CGTCACAAGCATCCACTCCT-3 primers, SUR013F and SUR227R, unique to the 5-
KIR62–3R 5-cacctgcatatgaatggtgg-3
mcSUR2B sequence. A third probe was designed to de-KIR62ORF5 5-GGCCAACGGAGCCATGCTGT-3
KIR62ORF3 5-ggacaaggaatccggagagatgc-3 tect both mesangial SUR2 transcripts and was a 4.3 kbp
KIR61ORF5 5-GGAAGATGCTGGCCAGGAAGAGC-3 Eco RI restriction fragment of pJGAR7. Multiple 20-g
KIR61ORF3 5-ggattctgatgggcactggtttc-3
aliquots from the same RNA harvest from 16KC2 cellsSUR2BORF5 5-GCAGGCGGTTGGAAGGTAGATCA-3
SUR2B3NT 5-catgtccgcacgaacgaacgag-3 were probed in Northern analysis with the described
SURS4508F 5-GGCTCTGGGAGGCTCT-3 probes. Changes in SUR2 gene expression in response
Upper case letters denote the forward primer and lower case letters the reverse to glibenclamide were studied in serum-deprived half-
primer.
confluent cultures, 24 and 48 hours following the addi-
tion of 5 M glibenclamide or vehicle. In these ex-
periments, 20 g aliquots of RNA were probed with
pJGAR7 during Northern analysis [28]. The 1.2 kbp cod-1 g of MC poly(A) RNA was used as template in
separate reverse transcription reactions that yielded 5- ing sequences of Kir6.1 and Kir6.2 were used as tem-
plates for specific probe generation in Northern analysisand 3-RACE ready single-stranded cDNA libraries.
The primary 5-RACE reactions were carried out with of RNA derived from primary MC and 16KC2 cells,
kidney cortex, and the positive control, heart. Mem-the primers UPM and GSP1B (Table 1) and nested 5-
RACE reactions with primers NUP and GSP3B. Primary branes were washed twice at 25C for 10 minutes in
2 standard sodium citrate (SSC)/0.1% sodium dodecyl3-RACE reactions were carried out with the primers
UPM and GSP2 and nested 3-RACE reactions with sulfate (SDS) and once at 60C for 20 minutes in 0.1
SSC/0.1% SDS. Membranes were autoradiographed andprimers NUP and GSP4B. The 0.6 and 2.5 kbp 5-RACE
and the 3.9 and 4.3 kbp 3-RACE generated amplicons films examined after 12 to 72 hours at 70C. These
experiments were conducted three times.were gel-purified for direct T-A subcloning into the
pCR2.1/TOPO vector. Automated fluorescent DNA se-
Microdissection of glomeruli and RNA isolationquencing of the mcSUR2B and rSUR2B RACE frag-
for RT-PCRments was performed on both strands by the ABI Prism
system with the Big Dye Terminator Sequencing pro- Male Munich-Wistar rats were sacrificed and microdis-
section of glomeruli and RNA isolation was performedtocol (Applied Biosystems, Foster City, CA, USA). Con-
sensus sequences were analyzed with MacVector 6.0 and as described previously [35].
AssemblyLIGN software (Genetics Computer Group,
Reverse transcription-polymerase chain reactionInc., Madison, WI, USA) [34]. Finally, to establish the
presence of full length, contiguous SUR2 coding se- Reverse transcription-polymerase chain reaction (RT-
PCR) was carried out on 1 g of total RNA extractedquences as predicted from the RACE cloning results,
gene-specific primers SUR2BORF5 and SUR2BORF3 from rat tissues, 20 ng of MC poly(A) RNA, or 5 L
of glomerular RNA isolate with a single tube sys-from rSUR2B and SURORF5 and SUR2BORF3 (from
mcSUR2B) (Table 1) were designed to amplify the full tem. The gene expression of previously described major
SUR2 splice variants was explored by RT-PCR in tis-coding sequences of the respective cDNAs. The 5-
RACE ready, single-stranded primary MC cDNA library sues and primary MC [6]. Primers SURS4508F and
SUR2B3NT were designed to specifically amplify a 446was used as template in RT-PCR reactions. Nucleotide
sequences were verified by bidirectional sequencing. bp SUR2B fragment and a 621 bp SUR2A fragment, to
fully resolve whether MC expressed the characteristic
Northern analysis N-terminal 38A exon of cardiac SUR2A [7, 11]. Primers,
SUR013F and SUR227R, were designed to specificallyTotal RNA was isolated from 16KC2 cells, primary
MC at passage 8 and from rat kidney, heart and brain amplify a 215 bp fragment of the unique 5-mcSUR2B
sequence. In separate experiments conducted to detectin RNA STAT-60 solution [34]. Twenty-microgram ali-
quots of total RNA were fractionated on 0.4 mol/L form- Kir6.x gene expression by primary MC, we used the
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Kir6.1 gene-specific primer pair, KIR61-2F and KIR61- bp sequence in the 2.5 kbp 5-RACE product’s 5-UTR.
In addition, the 0.6 kbp 5-RACE and 4.3 kbp 3-RACE2R, and the Kir6.2 gene-specific primer pair, KIR62-5F
and KIR62-3R, which were designed to amplify, respec- contigs comprise the novel 4.8 kbp mcSUR2B. The pres-
ence of the two separate mesangial SUR2B cDNAs wastively, a 402 bp and a 318 bp fragment. Amplicons were
visualized on ethidium bromide stained gels. Finally, to confirmed by end-to-end PCR with primers specific to
each coding region in reactions with cDNA templatesobtain templates for radiolabeling in Northern blotting
studies, the 1.2 kbp coding sequences of Kir6.1 and Kir6.2 from a single-stranded 5-RACE rat cDNA library.
The 6.7 kbp SUR2B reading frame is 4635 bp and thewere amplified by RT-PCR of MC poly(A) RNA and
heart total RNA with sequence-specific primer pairs for translated protein of 1535 aa is identical to rSUR2B.
The 4.8 kbp mcSUR2B reading frame is 2892 bp andKir6.1, KIR61ORF5 and KIR613ORF3, and for Kir6.2,
KIR62ORF5 and KIR62ORF3, respectively [15, 36]. Nu- translates a protein of 964 aa. This peptide has a novel
16 aa insert at the beginning of its amino terminus andcleotide sequences of the amplicons were verified by
DNA sequencing. Three independent experiments were is succeeded by 948 aa that are identical to rSUR2B
in the region spanning exons 13 to 38B. The peptideconducted.
alignment of the two mesangial SUR2 is displayed in
Immunoblotting Figure 1. Based on sequence identity between mcSUR2B
and rSUR2B, the predicted topology of mcSUR2B asConfluent primary MC and 16KC2 monolayers were
scraped into an ice-cold buffer (pH 7.4), containing 20 compared to rSUR2B is displayed in Figure 2 and dem-
onstrates that mcSUR2B lacks the initial 12 rSUR2Bmmol/L HEPES, 2 mmol/L ethylenediaminetetraacetic
acid (EDTA), 250 mmol/L sucrose, 0.1 mmol/L phenyl- exons [4]. This deletion renders a model whereby the
mcSUR2B N-terminus is intracytoplasmic. The putativemethylsulfonyl fluoride (PMSF), 1 mmol/L pepstatin,
and 1 mmol/L leupeptin, then immediately homogenized mcSUR2B retains the endoplasmic reticulum retention
signal RKQ that prevents cell surface expression of in-in a glass dounce [26]. Brain tissue was snap-frozen in
liquid nitrogen immediately following sacrifice of the completely assembled KATP. It also has two nucleotide
binding folds, NBF1 and NBF2, that contain the Walkeranimal and pulverized in a liquid nitrogen-cooled mortar,
then homogenized. Tissue debris and nuclei were pel- A and B motifs common to all SUR, and the terminal
exon 38B that imparts diazoxide sensitivity to SUR2B-leted out by centrifugation at 1000  g for 10 minutes
three times. Crude membrane preparations were ob- containing KATP [38]. McSUR2B is predicted to have six
transmembrane helices whose peptide sequence is identi-tained by centrifugation of clarified supernatants at
100,000  g for 60 minutes. Subsequently 20-g aliquots cal to the N-terminal transmembrane domain (TM2) of
rSUR2B. The binding sites for the potassium channelof total protein from membrane-enriched fractions of
MC, 16KC2 cells, or brain were separated by electropho- openers pinacidil and cromakalim were previously local-
ized to this area in SUR2A and SUR2B [39–42]. Theresis on 10% SDS polyacrylamide slab gels. Membranes
were blocked in 5% dry milk/0.1% Tween/1 PBS solu- cytoplasmic side of the homologous domain in SUR1
provides a high affinity-binding site for the sulfonylureation for 60 minutes and incubated with anti-SUR2 rabbit
antiserum (1:1000 dilution) that reacts with a conserved agents, tolbutamide and glibenclamide. Compared to
SUR1 the TM2 in SUR2 has a significantly lesser affinityregion of rat SUR2A/B close to the C-terminus. Follow-
ing incubation with anti-rabbit HRP-conjugated second- for sulfonylureas [43–45].
ary antibody, SUR2 proteins were demonstrated by a
Mesangial SUR2 gene expressionchemiluminescent assay [26, 34].
These studies were performed to determine whether
the smaller SUR2 4.8 kbp cDNA obtained by RACE
RESULTS
cloning represents the dominant 5.5 kbp transcript,
RACE cloning of mesangial SUR2 which we previously detected by Northern analysis with
a SUR2 probe (pJGAR7, 28). We generated a 1.9 kbpThe nested 5-RACE reaction generated amplicons of
0.6 kbp and 2.5 kbp and the nested 3-RACE reaction Sac I fragment from the 2.5 kbp 5-RACE product,
unique to the rSUR2B cDNA. Predictably, this fragmentyielded amplicons of sizes 3.9 kbp and 4.3 kbp. The 3.9
kbp 3-RACE amplicon was identical to the 4.3 kbp hybridized only to the mesangial SUR2 transcript at 7.5
kbp. Using PCR, a 215 bp probe was generated corre-product but was truncated by 400 bp in the 3 untrans-
lated region (UTR). Alignments of the 2.5 kbp 5-RACE sponding to the unique 5-sequence of mcSUR2B. This
probe preferentially hybridized to the novel 5.5 kb SUR2and 4.3 kbp 3-RACE contigs spanned the 4.6 kbp
rSUR2B cDNA coding region and reconstructed a 6.7 message, confirming that the 4.8 kbp cDNA represented
the 5.5 kb SUR2 mesangial transcript. Finally, the 4.3kbp SUR2B sequence. Within the coding sequence,
100% identity with the rSUR2B sequence was estab- kbp Eco RI fragment of pJGAR7 that contains sequence
common to both the 4.8 and 6.7 kbp cDNAs predictablylished [37]. Further analysis demonstrated a unique 160
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Fig. 1. Primary sequence of rat mesangial type 2 sulfonylurea receptors (SUR2). The respective 4635 bp and 2892 bp open reading frames of rat
SUR2B (rSUR2B) and mesangial SUR2B (mcSUR2B) cDNAs were translated, and the putative amino acid sequences are displayed. Vertical
bar (|) denotes sequence identity. The underscore ( ) defines the sequence unique to mcSUR2. Italics show the amino acids that correspond
to exon 13 of rSUR2B that begins region of identity between rSUR2B and mcSUR2B. Bold type illustrates the Walker A and B ATP-binding
motifs. Asterisks (*) denote the protein kinase A-dependent phosphorylation sites, open diamonds () are the protein kinase C-dependent
phosphorylation sites, and the boxed region () shows the terminal SUR2B-specific, alternatively spliced exon.
hybridized to SUR2 transcripts at 5.5 and 7.5 kb (Fig. A major difference among SUR2 splice variants is the
alternative usage of either the terminal 38A exon that3). Finally, to establish whether the novel mcSUR2B
splice variant was expressed in vivo, RT-PCR was per- characterizes SUR2A or its 38B counterpart that estab-
lishes SUR2B. With gene-specific primers, 38A/B exonformed on RNA template isolated from microdissected
rat glomeruli. Using a primer pair that amplified the usage was determined in MC. A 446 bp amplicon was
amplified in MC, signifying alternative splicing of onlyunique 5-sequence of mcSUR2B, we confirmed the gene
expression of the mcSUR2B splice variant in rat glomer- the 38B exon (Fig. 4A). In parallel studies of heart (posi-
tive control) and kidney, 446 and 621 bp amplicons wereuli. In similar RT-PCR reactions, a large amount of spe-
cific product was observed using RNA template from amplified in heart, but only a 446 bp amplicon was de-
tected in kidney. Collectively, these data support SUR2A16KC2 or MC (Fig. 4B).
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Fig. 2. Putative topology of the mesangial
SUR2 protein and rat SUR2B. (Top) The rat
mesangial SUR2B (mcSUR2B) protein is
comprised of a single transmembrane span-
ning domain (TM) with 6 helices that are
flanked by two cytoplasmic loops. Each loop
contains nucleotide-binding folds (NBF) with
Walker A and B motifs that bind and hy-
drolyze ATP. The N-terminus is predicted as
intracytoplasmic, distinct from other SUR.
The putative endoplasmic reticulum retention
signal RKQ is shown. Protein kinase A ()-
and protein kinase C ()-dependent phos-
phorylation sites and the proposed binding
sites of various sulfonylurea compounds are
indicated. (Bottom) Rat SUR2B topology.
and SUR2B isoform expression in heart, but only SUR2B Mesangial Kir6.1 and 6.2 gene expression
in kidney [6]. To establish mesangial Kir6.1/2 gene expression, RT-
Because our previous observations implied that sulfo- PCR was performed with gene-specific primers. In MC,
nylureas, possibly through SUR2B, regulate MC contrac- a 402 bp fragment corresponding to Kir6.1 was robustly
tility and extracellular matrix metabolism, investigations amplified, whereas the 318 bp fragment of Kir6.2 was
were carried out to determine whether glibenclamide minimally evident (Fig. 7A). As the Kir6.2 gene is in-
regulated the mesangial expression of the SUR2B gene. tronless [11], the possibility existed that amplification of
In two independent studies, glibenclamide (5 M) did contaminating genomic DNA had contributed to these
not influence SUR2B expression in serum-deprived MC results. However, PCR, in the absence of reverse tran-
after 48 hours of drug exposure (Fig. 5). Longer incuba- scription generated no Kir6.2 products negating this pos-
tion times were not evaluated. Because the 5.5 kb sibility. Lastly, in Northern analysis, transcripts of Kir6.1
SUR2B mesangial transcript became more evident dur- were strongly detected at 1.7 and 2.7 kb in primary MC,
ing growth of cells in culture (data not shown) and be- kidney cortex, whole kidney, and heart. The Kir6.2 tran-
cause Kir6.1 transcripts increased during embryonic de- script of 4.1 kb was only identified in the positive control
velopment, we sought to determine whether serum heart (Fig. 7B, C).
regulated SUR2B expression. Interestingly, the level of
the major 5.5 kbp transcript became undetectable follow-
DISCUSSIONing a 24-hour period of serum deprivation and this
change persisted for at least 48 hours. In contrast, serum- Data from Metzger and colleagues has previously im-
plied the presence of glomerular SUR [46, 47]. Thisdeprivation did not alter expression of the 7.5 kb tran-
script (Fig. 5). group demonstrated both low- and high-affinity gliben-
clamide binding in metabolically active preparations of
Mesangial SUR2 protein detection rat glomeruli. However, the cell type(s) responsible for
the binding were not unequivocally described and theUsing polyclonal anti-SUR2 antibody, multiple bands
were detected from Mr 50 to 170 kD in MC (Fig. 6). By presence of contaminating vasculature in their prepara-
tions may have accounted for the drug binding. This iscontrast, in the positive control brain tissue only a 170
kD band was visualized. In membrane-enriched prepara- plausible because the existence of glomerular SUR, as
a component of afferent arteriolar KATP, has been estab-tions of primary MC and 16KC2 cells, a dominant band
was detected at 108 kD, consistent with the predicted lished [48]. Moreover, sulfonylurea drug binding to glo-
merular KATP-bearing renin-producing cells also maysize of the translated mcSUR2B peptide. Lastly, lesser
signal intensity was evident at 170 kD. have accounted for their results [49].
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Fig. 3. Mesangial SUR2 gene expression. Differential identification of rat mesangial cell transcripts for SUR2B was carried out with gene-specific
probes in northern analysis as described in the Methods section. (A) Rat kidney SUR2B (rSUR2B) and mesangial SUR2B (mcSUR2B) cDNAs
are shown. Stippled portions correspond to regions of identity. Sac I sites (34 to 1939 bp) define an rSUR2B-specific probe. Eco RI sites
(2440 to 6715 bp) define a probe that detects rSUR2B and mcSUR2B transcripts (pJGAR7). A 215 bp 5-terminal fragment (13 to 227
bp) defines the mcSUR2B-specific probe. (B) The Sac I probe only detects the 7.5 kb SUR2B transcript. The mcSUR2B-specific probe strongly
hybridizes to the 5.5 kb transcript. The pJGAR7 probe hybridizes to transcripts at 5.5 and 7.5 kb.
Our data provide convincing evidence for the exis- of this clone may be attributable to an inability of our
RACE-based system to negotiate complex topology intence of at least two mesangial SUR2B, which likely
heterodimerize with Kir6.1 to form mesangial KATP. Two the 5-UTR. Nevertheless, the sequence of mcSUR2B,
the smaller mesangial SUR2B that corresponds to therat mesangial SUR2B cDNAs were RACE-cloned, and
the cDNAs corresponding to the two most abundantly 5.5 kb transcript, clearly identifies it as a member of
the SUR2 family. From aa 17 to 964, mcSUR2B sharesexpressed mesangial SUR2 transcripts of 5.5 and 7.5 kb
characterized by Asano et al [28]. To date, the longest identity with the region of rSUR2B that spans exons 13
to 38B. However, mcSUR2B is truncated at its N-ter-SUR2B clone that has been isolated is the 6.6 kb rSUR2B
cDNA obtained from a rat kidney library [37]. The cod- minus. This gene has a deletion of the 12 proximal N-ter-
minal rSUR2B exons and a unique 16 aa insert at itsing region of our 6.7 kb SUR2B cDNA was 4635 bp
and essentially identical to rSUR2B, except for several amino terminus, discriminating it from other SUR2
(Figs. 2 and 3). Our topological analysis of mcSUR2Bnucleotide differences that may represent species-spe-
cific variations and that do not affect the primary se- reveals a single, 6-helix transmembrane spanning do-
main. By contrast, rSUR2B has three transmembranequence. In addition, the 5-UTR of the 6.7 kb clone
contains a novel 160 bp sequence, which we presume domains (Fig. 3) [4, 37]. Additionally, the mcSUR2B
N-terminus is predicted to be intracytosolic, as opposedresulted from cell-specific alternative splicing.
Despite the 0.7 kbp difference in length compared to to rSUR2B and other SUR2 wherein the N-termi-
nus resides extracellularly [4]. Lastly, mcSUR2B retainsthe 5.5 kb mesangial SUR2B transcript, we ascertained
that our 4.8 kbp cDNA contains the same open reading the transmembrane domain corresponding to TM2 of
rSUR2B. The cytosolic side of this domain binds theframe as the larger message. Perhaps the foreshortening
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Fig. 4. Expression of SUR2 splice variants in rat glomerulus and mes-
angial cells (MC). RT-PCR reactions were carried out in rat heart,
kidney, primary MC, and microdissected glomeruli, with gene-specific
primers that define expression of mcSUR2B, SUR2A, or SUR2B as
described in the Methods section. Gene products were visualized on
ethidium bromide stained gels. (A) SUR2A and SUR2B are detected
in heart. In kidney and MC, only SUR2B is expressed. No gene product
is seen in the negative control (water). (B) The unique 215 bp 5-ter-
minal fragment of mcSUR2B is detected in 16KC2 and MC and microdis-
sected glomeruli. No gene product is detected in the negative control
(water).
Fig. 6. Detection of mesangial SUR2 proteins. Immunoblotting of
SUR2 proteins was carried out on membrane-enriched fractions of rat
brain, mesangial cells (MC) and 16KC2 cells. The rabbit polyclonal
SUR2 antiserum detects common epitopes of SUR2A and SUR2B near
their C-termini as described in the Methods section. In the positive
control tissue brain, the rat SUR2B is strongly detected at 170 kD. In
MC and 16KC2 cells, the mesangial SUR2B is detected at Mr 108 kD,
while the rat SUR2B is less strongly detected at Mr 170 kD.
lar mass of 108 kD of the dominant band agrees with
the size predicted from translation of the 2892 bp open
reading frame of the 4.8 kbp mcSUR2B clone. The less
Fig. 5. Serum deprivation induces differential gene expression of strongly evident 170 kD band most likely characterizes
SUR2B. Gene regulation of SUR2B by glibenclamide and serum was expression of the 6.7 kbp rSUR2B cDNA. Previous im-
examined. Subconfluent mesangial cell cultures were maintained in 20%
munoblotting studies of protein isolates from cell linesserum or serum-deprived and exposed to glibenclamide (5 M) for
times shown. In Northern analysis, a probe that detects both the 7.5 transformed by SUR2A or SUR2B cDNA clearly dem-
kb rat SUR2B and the 5.5 kb mesangial SUR2B transcript was used onstrated proteins with an apparent mass of 170 kD
(pJGAR7). Serum-stimulated cells express 5.5 and 7.5 kb transcripts.
[50]. Interestingly, these full-length proteins were notAfter a 24-hour serum deprivation, the 5.5 kb mesangial-specific tran-
script is undetectable and this down-regulation persists for at least detected from cardiac sarcolemma [51] or whole mouse
48 hours. Exposure to glibenclamide did not influence SUR2 gene kidney crude membrane preparations [52], althoughexpression.
these tissues express full size SUR2A and SUR2B, re-
spectively [7, 20, 37, 52]. Presumably, immunodetection
of full length SUR2 in MC (and murine cardiac sarco-
lemma and whole kidney crude membrane preparations)potassium channel opener agents, pinacidil and croma-
is difficult. On the other hand, the 108 kD band corre-kalim, with high affinity [39–42], and also contains a low-
sponding to the abundant 5.5 kb mcSUR2B transcriptaffinity sulfonylurea binding site [43–45].
In immunoblotting experiments, the apparent molecu- is convincingly demonstrated and the relative intensities
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Fig. 7. Mesangial Kir6.x gene expression.
RT-PCR reactions with gene-specific primers
of Kir6.1 and Kir6.2 were carried out on 16KC2
cells and mesangial cells (MC). Reaction prod-
ucts were visualized on an ethidium bromide-
stained gel. (A) Strong Kir6.1 gene expression
is shown for MC and 16KC2 cells, while only
minimal Kir6.2 gene expression is detected.
(B) Kir6.1 cDNA was used as probe in north-
ern analysis. Hybridization to transcripts at
sizes shown is seen in renal cortex, MC, 16KC2
cells, and the positive control, heart. (C) Paral-
lel studies with Kir6.2 cDNA only detected a
transcript in the heart.
of the 170 kD and 108 kD signals on immunoblotting pertension and the concomitant distensile forces. How-
ever, there was no alteration of MC SUR2 gene expres-roughly correspond to their hybridization signal intensi-
ties previously determined by Northern blotting [28]. sion by either stimulus, even after 48 hours of exposure
to glibenclamide and stretch. However, we did documentThe human SUR2 gene spans more than 100 kbp and
contains no less than 39 exons [11]. Multiple tissue-spe- that serum deprivation of 24 to 48 hours potently down-
regulated gene expression of the 5.5 kb mcSUR2B tran-cific splice variants of SUR2 have been documented in
Northern assays and by RT-PCR, and these variations script, while transcript levels of the 7.5 kb message re-
mained unchanged. The physiological consequence ofmay contribute to the functional diversity of KATP [11].
The cDNAs characterized by these studies shared exten- this differential expression is unknown.
In VSMC, SUR2B partners with Kir6.1 to form KATP,sive homology with mcSUR2B; however, the 5.5 kb tran-
script of mcSUR2B was not detected previously in cells and more rarely, Kir6.2 may represent the ion pore-
forming subunit. Analogously, for MC to furnish an ionor tissues evaluated, suggesting that MC carry out a
unique alternative splicing event. The two splice variants, pore channel to mesangial KATP, they must also express
Kir6.x. In MC, we established robust gene expression ofcardiac SUR2A and the vascular smooth muscle cell
(VSMC) SUR2B, differ in their expression of the 38A/B Kir6.1, and minimal Kir6.2 expression in RT-PCR and
Northern blotting studies. Consequently, our data favorC-terminal exon. A deletion of exon 38A, with preferen-
tial expression of exon 38B in SUR2B, renders VSMC the assembly of two mesangial KATP, heterodimers of
(rSUR2B:Kir6.1)4 or (mcSUR2B:Kir6.1)4 [22]. SeveralKATP sensitive to the K channel opener and vasodilator,
diazoxide [41, 42]. In contrast, cardiac KATP, a tetradimer investigations have established that the various SUR2
exhibit differential electrophysiological characteristicsof SUR2A and KIR6.2, is diazoxide-insensitive. Our re-
sults indicate the exclusive usage of exon 38B by MC [54, 55]. Based on a recent study of Kir6.2 knockout mice,
Kir6.1 represents the functional pore-forming subunit ofand kidney, consonant with the report of Beesley and
colleagues who characterized the expression of murine VSMC KATP [56]. With analogy to VSMC KATP, one of
the mesangial KATP (rSUR2B:Kir6.1)4 would be predictedkidney SUR2 [52].
Thus far, regulation of the constitutively expressed to be activated by the potassium channel openers, pinaci-
dil, nicorandil and diazoxide [39–42] and inhibited bySUR2 gene has not been defined. However, prolonged
exposure of pancreatic  cells to glibenclamide has been sulfonylureas [43–45]. In addition, this particular KATP
may be nucleoside diphosphate-regulated rather thanshown to increase SUR1 protein expression and to af-
fects its translocation from the cytosol to membrane [53]. ATP-inhibited [22, 57, 58]. Finally, the second mesangial
would be assembled as (mcSUR2B:Kir6.1)4 and couldWe examined the effects of cyclical mechanical stretch
(data not shown) and glibenclamide on mesangial SUR2 manifest an electrophysiologic profile different than
(rSUR2B:Kir6.1)4.gene expression because sulfonylureas are typically uti-
lized as therapy in diabetic individuals whose glomeruli Given the ubiquitous expression of KATP and their
regulation by sulfonylureas, the question arises as toare exposed to the pernicious effects of glomerular hy-
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receptors determines the pharmacological properties of ATP-sen-whether endogenous ligands for these channels exist [59].
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